NCT01945424View on ClinicalTrials.gov

Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry

CompletedOBSERVATIONAL
Enrollment

244

Participants

Timeline

Start Date

August 16, 2013

Primary Completion Date

September 15, 2019

Study Completion Date

September 15, 2019

Conditions
PregnancyInfluenza
Interventions
BIOLOGICAL

Quadrivalent Influenza Vaccine (QIV)

No Intervention as part of this protocol

Trial Locations (5)

Unknown

San Diego

Albany

Columbus

Harrisburg

Nashville

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01945424 - Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry | Biotech Hunter | Biotech Hunter